{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-098224","form_type":"8-K","ticker":"NMHI","cik":"0001947861","company_name":"Nature's Miracle Holding Inc.","filed_at":"2025-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.129627+00:00","generated_at":"2026-05-17T03:59:26.870010+00:00","sec_items":["1.01","2.03","3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nature's Miracle raises $2M via Series D preferred; enters $3M note with CEO affiliate","bullets":["Sold 500 Series D shares at $1k each ($500k) to Y.K. Capital; second $500k closing due by Oct 30, 2025; final $1M before Nasdaq/NYSE uplisting.","Series D carries 8% annual dividend, convertible at $0.1180 per share; conversion capped at 4.99% beneficial ownership.","Issued 50 Series A shares to GHS Investments at $1,200/share (12% dividend, convertible at $0.112) in exchange for consent to create Series B/C/D and $3M note to CEO James Li affiliate.","Filed amendments increasing Series B designated shares from 250 to 300; Series D Certificate of Designations filed with conversion price $0.1180.","Proceeds support potential uplisting; all securities sold unregistered under Section 4(a)(2)/Reg D."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-098224","json":"https://secwatch.observer/filing/0001213900-25-098224.json","markdown":"https://secwatch.observer/filing/0001213900-25-098224.md","text":"https://secwatch.observer/filing/0001213900-25-098224.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1947861/000121390025098224/0001213900-25-098224-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1947861/000121390025098224/ea0260989-8k_natures.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:59:26.870010+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19b693eeb07b92ecc30852f9771d7885e77d0dcd","claim":"Nature's Miracle Holding Inc.: Filed Amendment No. 1 to Certificate of Designations for Series A Preferred Stock to increase designated shares of Series B Preferred Stock from 250 to 300 (effective 2025-10-07).","evidence_excerpt":"On October 7, 2025, pursuant to the SPA, the Company filed Amendment No. 1 to the Certificate of Designations for the Series A Preferred Stock, solely to increase the number of designated shares of Series B Preferred Stock from 250 to 300.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1947861/000121390025098224/0001213900-25-098224-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-10-07"}],"fact_type":"governance_change"},{"claim_id":"38dc746baa51eda202ebaa3ba318b1e705f55c52","claim":"Nature's Miracle Holding Inc.: Filed Certificate of Designations and Amendment No. 1 for Series D Preferred Stock, establishing 2,000 shares with a conversion price of $0.1180 (effective 2025-09-30).","evidence_excerpt":"On September 30, 2025, pursuant to the Purchase Agreement, the Company filed the Certificate of Designations for the Series D Preferred Stock, and to correct certain discrepancies in the previously filed Certificate of Designations for the Series D Preferred Stock, on October 7, 2025, the Company filed Amendment No. 1 to the Certificate of Designations for the Series D Preferred Stock (together the “ Certificate of Designations ”), with the Secretary of State of the State of Delaware for the purpose of establishing and designating the Series D Preferred Stock.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1947861/000121390025098224/0001213900-25-098224-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-09-30"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}